Kurt Lesh
Family Medicine · Colorado Spgs, CONPI 1780629824
Payments from drug & device makers
Across 475 payments — averaging $973.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$128K
- Merck$106K
- AbbVie$102K
- Eisai Inc.$94K
- Regeneron$10K
- Pfizer$9K
- plus $13K from 31 others
Across 4 payments — averaging $435.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$2K
What the payments were for
- Travel & lodging$1,89727%
- Food & beverage$5,03372%
- Education$1051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 110 | $127,837 |
| Merck | 28 | $106,070 |
| AbbVie(2 entities) | 101 | $102,082 |
| Eisai Inc. | 21 | $94,034 |
| Regeneron | 2 | $9,723 |
| Pfizer | 21 | $9,129 |
| Sanofi Pasteur Inc. | 1 | $5,000 |
| AstraZeneca | 33 | $2,953 |
| Noven Pharmaceuticals, Inc. | 6 | $2,250 |
| Amgen(2 entities) | 20 | $574 |
| Boehringer Ingelheim | 22 | $447 |
| Lilly USA, LLC | 23 | $249 |
| Astellas Pharma US Inc | 7 | $223 |
| Johnson & Johnson | 12 | $195 |
| GSK | 5 | $186 |
| Amarin Pharma, Inc. | 10 | $181 |
| Esperion Therapeutics, Inc. | 4 | $179 |
| E.r. Squibb & Sons, L.L.C. | 9 | $152 |
| W. L. Gore & Associates, Inc. | 1 | $148 |
| Sanofi-aventis U.S. LLC | 6 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $88 |
| Kowa Pharmaceuticals America, Inc. | 6 | $76 |
| Nevro Corp. | 2 | $54 |
| Genentech USA, Inc. | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Bausch Health US, LLC | 2 | $26 |
| Optinose US, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Mannkind Corporation | 1 | $15 |
| Radius Health, Inc. | 1 | $13 |
| Vertiflex, Inc. | 1 | $12 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI AEROSPHERE$249
- EXCLUDER AAA Endoprosthesis$148
- NEXLIZET$125
- NEXLETOL$125
- Dayvigo$125
- ELIQUIS$109
- BEXSERO$109
- EVENITY$109
- Repatha$107
- FARXIGA$103
How this compares
$462,206 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Colorado Spgs
- Charles BirdColorado Spgs$477K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
- Astrid LampeyFraser$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.